Current anti-cancer drugs, including paclitaxel, doxorubicin, epirubicin, lapatinib, gefitibin, imatinib and cisplatin, have been confirmed to mediating their cytotoxic and cytostatic functions through FOXO3 and FOXM1. The gene discussed is FOXO3; the disease is cancer.